Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20
As a doctor, theres a lot of burden on your shoulders when you are prescribing something with insufficient evidence, but the patients insist on giving it a try. With no formal approvals surrounding their use from regulatory bodies like the Drugs Controller General of India (DCGI), they are considered off-label treatments
Great product, super fast delivery Excellent service
Cardiovascular/Anticoagulants: The blood thinner Eliquis (apixaban, BMS/Pfizer) netted $12.2 B , and Xarelto (rivaroxaban) ~$4.7 B
Peptides that interfere with myostatin signaling are studied in the context of muscular dystrophy and sarcopenia research models
US$ 26.70
US$ 26.33
US$ 27.16
US$ 21.48
US$ 25.28
US$ 20.98
US$ 25.48
US$ 25.21
